Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Vehicle-controlled, Study to Evaluate Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)

NCT04314362 is registered in ClinicalTrials.gov with Azura Ophthalmics as lead sponsor.

NCT NCT04314362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04314362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Vehicle-controlled, Study to Evaluate Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)
Lead sponsor
Azura Ophthalmics
Phase
Phase 2/3
Overall status
Completed
Start date
July 14, 2020
Completion date
January 6, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meibomian gland dysfunction